Literature DB >> 3639115

Sensitive assay for neutralizing antibodies against AIDS-related viruses (HTLV-III/LAV).

S Harada, D T Purtilo, Y Koyanagi, J Sonnabend, N Yamamoto.   

Abstract

A sensitive assay for neutralizing antibodies (NA) against AIDS-related viruses (HTLV-III and LAV) was developed, using human T-cell lymphotropic virus type-I (HTLV-I)-bearing and HTLV-III-susceptible MT-4 cells. NA to HTLV-III in 21 patients with acquired immune deficiency syndrome (AIDS), 10 individuals with AIDS-related complex (ARC), 20 healthy male homosexuals, and 10 healthy male controls were titrated. Antibodies to HTLV-III were also detected by indirect immunofluorescence (IF). The assay was sensitive up to a dilution of 1:10 000. Sera from patients with AIDS showed a geometric mean titer (GMT) of NA of 1:475, whereas much higher GMTs (1:1318 and 1:1009) were observed in patients with ARC and healthy male homosexuals, respectively. Moreover, titers of NA significantly correlated with the levels of anti-HTLV-III antibodies detected by IF.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3639115     DOI: 10.1016/0022-1759(86)90163-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  Naturally occurring V1-env region variants mediate simian immunodeficiency virus SIVmac escape from high-titer neutralizing antibodies induced by a protective subunit vaccine.

Authors:  H Petry; K Pekrun; G Hunsmann; E Jurkiewicz; W Lüke
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization.

Authors:  J A McKeating; A McKnight; J P Moore
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

3.  Densitometric analysis of Western blot (immunoblot) assays for human immunodeficiency virus antibodies and correlation with clinical status.

Authors:  G Schmidt; K Amiraian; H Frey; R W Stevens; D S Berns
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

4.  Identification of the V1 region as a linear neutralizing epitope of the simian immunodeficiency virus SIVmac envelope glycoprotein.

Authors:  E Jurkiewicz; G Hunsmann; J Schäffner; T Nisslein; W Lüke; H Petry
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  A simple assay based on HIV infection preventing the reclustering of MT-4 cells.

Authors:  G Szucs; J L Melnick; F B Hollinger
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

6.  Method for detection of simian immunodeficiency virus neutralizing antibodies using a noncommercial antigen capture enzyme-linked immunosorbent assay.

Authors:  M J Welch; M E Thouless
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

7.  Simian immunodeficiency virus from African green monkeys.

Authors:  M D Daniel; Y Li; Y M Naidu; P J Durda; D K Schmidt; C D Troup; D P Silva; J J MacKey; H W Kestler; P K Sehgal
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.